Haematologica (Sep 2013)
SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype
- Valeria Visconte,
- Ali Tabarroki,
- Heesun J. Rogers,
- Edy Hasrouni,
- Fabiola Traina,
- Hideki Makishima,
- Betty K. Hamilton,
- Yang Liu,
- Christine O’Keefe,
- Alan Lichtin,
- Leonard Horwitz,
- Mikkael A. Sekeres,
- Fred H. Hsieh,
- Ramon V. Tiu
Affiliations
- Valeria Visconte
- Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
- Ali Tabarroki
- Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
- Heesun J. Rogers
- Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH, USA
- Edy Hasrouni
- Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
- Fabiola Traina
- Hematology and Hemotherapy Center, National Institute of Blood, School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil
- Hideki Makishima
- Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
- Betty K. Hamilton
- Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
- Yang Liu
- Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
- Christine O’Keefe
- Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
- Alan Lichtin
- Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
- Leonard Horwitz
- Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
- Mikkael A. Sekeres
- Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA;Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
- Fred H. Hsieh
- Department of Pulmonary, Allergy and Critical Care Medicine, Cleveland Clinic, Respiratory Institute, Cleveland, OH, USA
- Ramon V. Tiu
- Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
- DOI
- https://doi.org/10.3324/haematol.2013.090506
- Journal volume & issue
-
Vol. 98,
no. 9
Abstract
No abstracts available.